BioWave Corporation

Biowave Corporation is a neuromodulation pain therapy company whose major goal is to help physicians, physical therapists and athletic trainers manage their patients' or athletes pain and reduce or eliminate the use of opiates, NSAIDs and their associated side effects. Biowave devices deliver a therapeutic electrical signal into deep tissue in the body blocking the transmission of pain. Biowave's pain therapy systems have received marketing clearance approval from the FDA and are designed to treat musculoskeletal pain that is chronic, acute or post-operative in nature and located in the low back, cervical spine, shoulder, elbow, wrist, hand, hip, knee, ankle and foot. Clinical studies have shown that following a 30 minute treatment, benefits include an immediate 75% average reduction in pain and a significant increase in function including an increase in range of motion, decrease in muscle spasm and decrease in stiffness, all of which last for up to 24 hours post treatment, without the side effects that are common to drugs, injection therapies, surgery and implanted devices. Empirically, Biowave has been reported to provide particularly profound pain relief for tendon and ligament related issues including acute or chronic tendinopathies and joint sprains, respectively.